Total trials
134
Active
30
Phase 3
0
Total enrollment
16,903
Pipeline matrix
Showing 2 of 2 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Poractant alfa | — | — | — | — | — | 1 | |
| Calfactant | — | — | — | — | — | 1 |
Next readouts
- 2027-02-20
Top conditions
- Pain6
- Pain Management6
- Exercise4
- Postoperative Pain4
- Anxiety4
- Analgesia3
- Pain, Postoperative3
- Anesthesia3
Frequently asked questions about Uludag University
- How many clinical trials does Uludag University have on ClinicalTrials.gov?
- Uludag University is listed as the lead sponsor on 134 clinical trials in ClinicalTrials.gov, 30 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Uludag University's trials are in Phase 3?
- 0 of Uludag University's trials are in Phase 3, spread across 2 active drug programs.
- What therapeutic areas does Uludag University focus on?
- Uludag University's most-studied conditions on ClinicalTrials.gov are Pain, Pain Management, Exercise, Postoperative Pain, Anxiety.
- When are Uludag University's next clinical trial readouts?
- Uludag University has 1 upcoming primary-completion readout tracked here; the soonest is “Calfactant vs Poractant Alfa Using a Less Invasive Technique in Preterm Infants With Respiratory Distress Syndrome”, expected around 2027-02-20.